Edesa Biotech annual gross margin
2012
2013
2014
2015
2016
2017
2019
2020
Edesa Biotech's gross margin was 94.65% for fiscal 2020.
View full Edesa Biotech company overview| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2020 | 2020-09-30 | 94.65% | +19.30 pp |
| 2019 | 2019-09-30 | 75.35% | — |
| 2017 | 2017-09-30 | −400.08% | −435.72 pp |
| 2016 | 2016-09-30 | 35.63% | +12.19 pp |
| 2015 | 2015-09-30 | 23.44% | — |
| 2014 | 2014-08-31 | −26.07% | −115.56 pp |
| 2013 | 2013-08-31 | 89.49% | +138.52 pp |
| 2012 | 2012-08-31 | −49.03% | — |
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q4 2020 | 2020-09-30 | −362.80% | −438.12 pp |
| Q3 2020 | 2020-06-30 | 98.66% | −1.34 pp |
| Q2 2020 | 2020-03-31 | 90.92% | — |
| Q1 2020 | 2019-12-31 | 96.50% | — |
| Q4 2019 | 2019-09-30 | 75.32% | — |
| Q2 2019 | 2019-06-30 | 100.00% | — |
| Q2 2018 | 2018-03-31 | −2.45% | +10.91 pp |
| Q1 2018 | 2017-12-31 | 86.33% | +41.71 pp |
| Q2 2017 | 2017-03-31 | −13.37% | −30.97 pp |
| Q1 2017 | 2016-12-31 | 44.62% | +8.54 pp |
| Q4 2016 | 2016-09-30 | 57.40% | −37.72 pp |
| Q3 2016 | 2016-06-30 | 33.74% | +80.81 pp |
| Q2 2016 | 2016-03-31 | 17.60% | +47.17 pp |
| Q1 2016 | 2015-12-31 | 36.07% | −18.82 pp |
| Q4 2015 | 2015-09-30 | 95.12% | — |
| Q3 2015 | 2015-06-30 | −47.07% | +56.83 pp |
| Q2 2015 | 2015-03-31 | −29.57% | −0.19 pp |
| Q1 2015 | 2014-12-31 | 54.89% | +204.67 pp |
| Q4 2014 | 2014-08-31 | 79.17% | — |
| Q3 2014 | 2014-06-30 | −103.90% | — |
| Q2 2014 | 2014-03-31 | −29.39% | — |
| Q1 2014 | 2013-12-31 | −149.78% | — |
Over the last five fiscal years, Edesa Biotech's gross margin increased from 23.44% to 94.65%, a change of +71.20 percentage points. The latest reported quarter, Q4 2020, shows −362.80%.
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Edesa Biotech source filings ↗